Thomas James B, Giddings Angela M, Wiethe Robert W, Olepu Srinivas, Warner Keith R, Sarret Philippe, Gendron Louis, Longpre Jean-Michel, Zhang Yanan, Runyon Scott P, Gilmour Brian P
Center for Organic and Medicinal Chemistry, Research Triangle Institute , P.O. Box 12194, 3040 Cornwallis Road, Research Triangle Park, North Carolina 27709, United States.
J Med Chem. 2014 Sep 11;57(17):7472-7. doi: 10.1021/jm500857r. Epub 2014 Aug 26.
Compounds acting via the neurotensin receptor type 2 (NTS2) are known to be active in animal models of acute and chronic pain. To identify novel NTS2 selective analgesics, we searched for NTS2 selective nonpeptide compounds using a FLIPR assay and identified the title compound (NTRC-824, 5) that, to our knowledge, is the first nonpeptide that is selective for NTS2 versus NTS1 and behaves like the endogenous ligand neurotensin in the functional assay.
已知通过神经降压素2型受体(NTS2)起作用的化合物在急慢性疼痛的动物模型中具有活性。为了鉴定新型NTS2选择性镇痛药,我们使用荧光成像板读数器(FLIPR)检测法寻找NTS2选择性非肽化合物,并鉴定出标题化合物(NTRC - 824,5),据我们所知,它是第一个对NTS2比对NTS1具有选择性的非肽,并且在功能检测中表现得像内源性配体神经降压素。